XNXuan Nie

Xuan Nie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuan Nie has a total of 129 co-authors. Here are the top co-authors by number of shared publications:

  • Ye-Zi You

    Department of Polymer Science and Engineering University of Science and Technology of China Hefei China

    19 shared publications
  • Chun-Yan Hong

    Department of Polymer Science and Engineering University of Science and Technology of China Hefei China

    9 shared publications
  • Ze Zhang

    Department of Polymer Science and Engineering University of Science and Technology of China Hefei China

    9 shared publications
  • Lei Xia

    CAS Key Laboratory of Soft Matter Chemistry Department of Polymer Science and Engineering University of Science and Technology of China Hefei 230026 China

    8 shared publications
  • Wei You

    Department of Polymer Science and Engineering

    8 shared publications
  • Fei Wang

    Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine

    6 shared publications

Latest Publications

  • Open Access

    Nanoadjuvant-based membrane poration boosts antitumor immunity via modulating mitochondrial metabolism to downregulate PD-L1 and upregulate STING

    by Wei You, Fan Gao, Hai-Li Wang, Ai-Zong Shen, Ze Zhang, Xuan Nie, Wei-Qiang Huang, Long-Hai Wang, Ye-Zi You

  • Reprogramming Proton-Coupled Electron Transfer in Living Cancer Cells to Eradicate Tumors

    by Bo-Yu Wang, Shun-Ran Peng, Wei You, Fan Gao, Guang Chen, Li-Qin Tang, Ze Zhang, Xuan Nie, Wei-Qiang Huang, Long-Hai Wang, et al.

    Intracellular proton-coupled electron transfer (PCET) governs cellular metabolism and fate, and its dysregulation is closely associated with disease progression. In normal cells, PCET into the electron transport chain supports ATP production and cellular growth. In cancer cells, however, overexpressed lactate dehydrogenase (LDH) redirects PCET to pyruvate, producing lactate and thereby sustaining tumor growth, proliferation, and metastasis. Reprogramming LDH-driven PCET in living tumors therefore represents an attractive antitumor strategy, yet no artificial catalyst has been shown to outcompete LDH and reprogram PCET in living cells. Here, we report an organoiridium catalyst, IrIII(Cp*)-CN, that captures proton-coupled electrons from NADH and transfers them to protons to generate H2 under ultrasound irradiation at physiological pH. In living cancer cells, IrIII(Cp*)-CN outcompetes LDH and redirects LDH-driven pyruvate reduction and lactate production toward proton reduction and H2 generation. This PCET-reprogramming process converts a tumor-promoting, lactate-producing reaction into a tumor-suppressive, H2-generating reaction, suppressing lactate and ATP production and markedly inhibiting tumor growth with minimal toxicity to normal cells and tissues. These findings establish a framework for reprogramming intracellular PCET via artificial catalysts that outcompete endogenous enzymes, offering a strategy for treating diseases associated with dysregulated cellular redox metabolism.

  • Open Access

    Enantioselective Reductive Alkenylation of α‐CF 2 H (‐CF 3 ) Amino Halides: Rapid Access to Chiral α‐CF 2 H (‐CF 3 ) Allylamines

    by Peng Liu, Kuiliang Li, Yan He, Chen‐Hui Jiang, Ruo‐Xing Jin, Duo‐Duo Hu, Wei‐Cheng Zhao, Xuan Nie, Shang‐Zheng Sun, Xi‐Sheng Wang

    The incorporation of fluoroalkyl groups into drug candidates has garnered increasing attention in the pharmaceutical industry due to their ability to modulate lipophilicity, permeability, metabolic stability, and binding affinity. Despite significant advances realized, the means to introducing fluoroalkyl groups such as ─CF 2 H or ─CF 3 in an enantioselective manner remain scarce. Herein, we report a Ni‐catalyzed enantioselective reductive alkenylation of α‐CF 2 H or ─CF 3 amino chlorides with vinyl iodides. This method provides an efficient and modular technique for constructing stereocenters bearing a fluoroalkyl group. A key to success was the incorporation of an arylamide moiety with the substrates, which stabilizes the α‐fluoroalkyl radical intermediate, thus offering a de novo approach to access enantioenriched α‐CF 2 H (─CF 3 ) allylamines. Our protocol is characterized by its mild reaction conditions, broad substrate scope, as well as excellent enantio—and chemo‐selectivity, even in the context of late‐stage functionalization.


  • Open Access

    S/O and vinyl isomerization enables ultrafast cationic ring-opening polymerization toward CO2-derived polythioester with migrated in-chain C=C substituents

    by Zong-Bin Lu, Shun-Ran Peng, Zhe Wang, Yu Xiong, Lei Xia, Guang Chen, Xuan Nie, Chun-Yan Hong, Ze Zhang, Ye-Zi You

    Developing high-performance CO2-based polymers is promising to address the challenges of CO2 sequestration and the environmental impact of petroleum-based plastics. The δ-lactone 3-ethylidene-6-vinyltetrahydro-2H-pyran-2-one and its derivatives, synthesized from CO2 with 1,3-butadiene, have emerged as very promising CO2-derived monomers. However, their general ring-opening polymerizations face challenges with thermodynamics and kinetics, generally resulting in long reaction times, low conversions, and low-molecular-weight polyesters with poor mechanical properties. Herein, we report a dual isomerization-driven cationic ring-opening polymerization (DI-CROP) of a CO2-derived thionolactone, 3-ethyl-6-vinyltetrahydro-2H-pyran-2-thione, in which the relayed S/O and vinyl isomerizations significantly enhance polymerization activity, enabling the rapid synthesis of high-molecular-weight CO2-based polythioesters, achieving near-quantitative conversion within just a few minutes. Also, the relayed S/O and vinyl isomerizations in DI-CROP can easily migrate C=C substituents on the ring of thionolactone into its backbone. These features further enable the production of sustainable CO2-based materials through efficient copolymerization and post-polymerization functionalization. This study enriches the realm of isomerization-driven polymerizations, and provides a new synthetic approach to CO2-derived polymeric materials.


  • Open Access

    Targeting phosphatidylserine in tumor cell membranes with a zinc-containing molecule to efficiently combat tumor metastasis

    by Xiao-Hong Zhou, Jia-Wei Wang, Wei You, Fan Gao, Zhe Wang, Hong-Jie Gao, Ai-Zong Shen, Yang-Huan Ou, Xiang Zhan, Xuan Nie, et al.

    Metal drugs, such as platinum drugs, are widely used in tumor treatment. However, most traditional tumor treatments face the risk of failure due to the ineffective control over drug resistance and tumor metastasis. Targeting the cell membrane and disrupting its function to combat drug resistance and metastasis is a promising strategy. Nevertheless, membranolytic drugs always cause significant cytotoxicity. In this study, we developed a zinc-containing molecule to selectively kill tumor cells by targeting phosphatidylserine in the tumor cell membrane, which is commonly distributed in the outer cell membrane of tumor cells. Herein, a structurally optimized amphiphilic zinc-containing molecule, 2aZn, was developed by screening the appropriate hydrophobic tail and linker. This functional molecule can disrupt the tumor cell membrane to kill various types of tumor cells with minimal damage to normal tissue. After repeated stimulation, no obvious drug resistance was observed. Importantly, 2aZn could successfully combat tumor metastasis by destroying the cell membrane and reducing the capacity of cells to invade. As a result, zinc-containing molecules have the potential to overcome drug resistance and tumor metastasis in the treatment of tumors, providing a new perspective for the design of effective antitumour medications.


  • Top Cited Papers
    Open Access

    Peptide-based inflammation-responsive implant coating sequentially regulates bone regeneration to enhance interfacial osseointegration

    by Wei Zhou, Yang Liu, Xuan Nie, Chen Zhu, Liming Xiong, Jing Zhou, Wei Huang

    Aseptic loosening is the primary cause of bone prosthesis failure, commonly attributed to inadequate osseointegration due to coatings misaligned with bone regeneration. Here, we modify the titanium surface with a mussel-inspired peptide to form a 3,4-dihydroxyphenylalanine (DOPA)-rich coating, then graft N3-K15-PVGLIG-K23 (P1) and N3-Y5-PVGLIG-K23 (P2), which are composed of anti-inflammatory (K23), angiogenic (K15), osteogenic (Y5), and inflammation-responsive (PVGLIG) sequences, onto the surface via click chemistry, forming the DOPA-P1@P2 coating. DOPA-P1@P2 promotes bone regeneration through sequential regulation. In the initial stage, the outermost K23 induces M2 macrophage polarization, establishing a pro-regenerative immune microenvironment. Subsequently, K15 and Y5, exposed by the release of K23, enhance angiogenesis and osteogenesis. In the final stage, DOPA-P1@P2 outperforms the TiO₂ control, showing a 161% increase in maximal push-out force, a 207% increase in bone volume fraction, and a 1409% increase in bone-to-implant contact. These findings show that DOPA-P1@P2 efficiently enhances interfacial osseointegration by sequentially regulating bone regeneration, providing viable insights into coating design.


  • Open Access

    CF2H-synthon enables asymmetric radical difluoroalkylation for synthesis of chiral difluoromethylated amines

    by Peng Liu, Yan He, Chen-Hui Jiang, Wei-Ran Ren, Ruo-Xing Jin, Ting Zhang, Wang-Xuan Chen, Xuan Nie, Xi-Sheng Wang

    The difluoromethyl group is a crucial fluorinated moiety with distinctive biological properties, and the synthesis of chiral CF₂H-containing analogs has been recognized as a powerful strategy in drug design. To date, the most established method for accessing enantioenriched difluoromethyl compounds involves the enantioselective functionalization of nucleophilic and electrophilic CF₂H synthons. However, this approach is limited by lower reactivity and reduced enantioselectivity. Leveraging the unique fluorine effect, we design and synthesize a radical CF₂H synthon by incorporating isoindolinone into alkyl halides for asymmetric radical transformation. Here, we report an efficient strategy for the asymmetric construction of carbon stereocenters featuring a difluoromethyl group via nickel-catalyzed Negishi cross-coupling. This approach demonstrates mild reaction conditions and excellent enantioselectivity. Given that optically pure difluoromethylated amines and isoindolinones are key structural motifs in bioactive compounds, this strategy offers a practical solution for the efficient synthesis of CF₂H-containing chiral drug-like molecules.


  • Autophagosomes coated in situ with nanodots act as personalized cancer vaccines

    by Wei-Qiang Huang, Wei You, Ya-Qi Zhu, Fan Gao, Zhi-Zhi Wu, Guang Chen, Jun Xiao, Qi Shao, Long-Hai Wang, Xuan Nie, et al.

    Autophagosome cancer vaccines can promote cross-presentation of multiple tumour antigens and induce cross-reactive T cell responses. However, so far, there is no effective method for obtaining a highly immunogenic autophagosomal cancer vaccine because autophagosomes, once formed, quickly fuse with lysosomes and cannot easily escape from cells. Here we report a functional Ti2NX nanodot that caps the autophagosome membrane lipid phosphatidylinositol-4-phosphate, blocking the fusion of autophagosomes with lysosomes and producing stable nanodot-coated autophagosomes in tumours. The formed nanodot-coated autophagosomes can escape from cancer cells to lymph nodes, where they activate tumour-specific T cells. We show that our approach reduces tumour burden and provide long-term immune surveillance protection for cured mice. This work provides a method for the direct formation of personalized autophagosome-based cancer vaccines in vivo, offering a promising strategy for tumour treatment.


  • Fe-based nanozyme with photothermal activity prepared from polymerization-induced self-assembly assays boosts the recovery of bacteria-infected wounds

    by Xuan Nie, Ling Fu, An-Pin Guo, Lei Zhang, Shao-Hu Huo, Wen Zhang, Zhao-Lin Chen, Xiang Zhan, Li-Qin Tang, Fei Wang